Kurt Peeters

 Kurt Peeters, MSc, PhD, Chief Operating Officer

KurtPeetersDr. Peeters holds a PhD in Developmental Biology from the University of Leuven, Belgium and spent all of his professional career in the clinical development business. His extensive operational experience covers many aspects of clinical research, including study initiation and management, site monitoring, sample management, kit production, and various environments, including academic, laboratory, CRO and pharma settings.

Prior to joining HistoGeneX in September 2017, Dr. Kurt Peeters was VP and Managing Director at LabCorp and globally responsible for Investigator Services and for Asia-Pacific Operations for its Covance Central Laboratory Services division. He was instrumental in the significant growth of LabCorp’s clinical trials business outside of the US by establishing successful collaborations and executing on M&A’s.

Before his responsibilities for Operations and General Management, Dr. Peeters held several positions of increasing responsibility in Quality Assurance, setting up and auditing various CAP- and ISO-based quality processes and systems, qualification and ongoing assessment of different partners in the drug development process, investigator site audits and business process management. His experience includes on-site audits in 25+ countries worldwide.